Bill

Bill > HR1829


US HR1829

US HR1829
Pharmacy Benefit Manager Accountability Study Act of 2021


summary

Introduced
03/11/2021
In Committee
03/12/2021
Crossed Over
Passed
Dead
01/03/2023

Introduced Session

117th Congress

Bill Summary

A BILL To require the Government Accountability Office to study the role pharmaceutical benefit managers play in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other pur- poses.

AI Summary

This bill requires the Government Accountability Office (GAO) to study the role of pharmacy benefit managers (PBMs) in the pharmaceutical supply chain. The study will examine the state of competition among PBMs, their use of rebates and fees, whether they structure formularies to favor high-rebate drugs, prior authorization approval times, the use of step therapy, and the extent to which PBMs charge payors more than they pay pharmacies for drugs. The bill also requires the GAO to provide recommendations for legislative action to lower drug costs for consumers and payors, improve the efficiency of the supply chain by lowering intermediary costs, enhance competition in PBM services, and increase transparency in PBM practices.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (30)

Last Action

Referred to the Subcommittee on Health. (on 03/12/2021)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...